C52H47N5O5
Neat
821.98
-20°C
Room Temperature
142217-79-6; (2R, 3S, 5S)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]Cyclopentanone; (2R, 3S, 5S)-5-(2-(((4-Methoxyphenyl)diphenylmethyl)amino)-6-(phenylmethoxy)-9H-purin-9-yl)-3-(phenylmethoxy)-2-((phenylmethoxy)methyl)cyclopentanone; RefChem:206796; (2R, 3S, 5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanone; Entecavir Impurity 2; MFCD13185974; (2R, 3S, 5S)-3-(BENZYLOXY)-5-[2-[[(4-METHOXYPHENYL)DIPHENYLMETHYL]AMINO]-6-(BENZYLOXY)-9H-PURIN-9-YL]-2-(BENZYLOXYMETHYL)CYCLOPENTANONE; (2R, 3S, 5S)-5-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-one; (2R, 3S, 5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)-amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanone (>85%); Cyclopentanone, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (2R, 3S, 5S)-; Entecavir Impurity 13; (2R, 3S, 5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)-amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanone; C52H47N5O5; SCHEMBL8781121; SCHEMBL31689350; DTXSID60678507; AKOS016006312; AC-5921; (2R, 3S and 5S)-3-benzyloxy-5-[6-benzyloxy-2-[[(4-methoxyphenyl)-diphenyl-methyl]amino]purin-9-yl]-2-(benzyloxymethyl)cyclopentanone
(2R, 3S and 5S)-5-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-one
InChI=1S/C52H47N5O5/c1-59-43-29-27-42(28-30-43)52(40-23-13-5-14-24-40,41-25-15-6-16-26-41)56-51-54-49-47(50(55-51)62-34-39-21-11-4-12-22-39)53-36-57(49)45-31-46(61-33-38-19-9-3-10-20-38)44(48(45)58)35-60-32-37-17-7-2-8-18-37/h2-30,36,44-46H,31-35H2,1H3,(H,54,55,56)/t44-,45+,46+/m1/s1